How have BFRG shares performed in 2024?

Bullfrog AI's stock was trading at $3.26 at the beginning of 2024. Since then, BFRG shares have increased by 53.7% and is now trading at $5.01. View the best growth stocks for 2024 here .

When is Bullfrog AI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our BFRG earnings forecast .

How were Bullfrog AI's earnings last quarter?

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) announced its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.21) earnings per share (EPS) for the quarter. The company earned $0.07 million during the quarter.

When did Bullfrog AI IPO?

(BFRG) raised $8 million in an IPO on Tuesday, February 14th 2023. The company issued 1,300,000 shares at a price of $6.50 per share. WallachBeth Capital and Kingswood Capital Markets acted as the underwriters for the IPO.

How do I buy shares of Bullfrog AI?

Shares of BFRG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BFRG

Bullfrog AI (BFRG) Stock Price, News & Analysis

$5.01

+0.42 (+9.15%)

(As of 02/9/2024 08:56 PM ET)

Compare

Today's Range: $4.40
▼
$5.05
50-Day Range: $2.41
▼
$7.40
52-Week Range: $2.36
▼
$9.50

Volume: 395,000 shs
Average Volume: 5.54 million shs
Market Capitalization: $30.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Bullfrog AI alerts:

About Bullfrog AI Stock (NASDAQ:BFRG)

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

BFRG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BFRG Stock News Headlines

January 19, 2024 | marketbeat.com

Bullfrog AI: advancing technologies in leaps and bounds

Bullfrog AI is an emerging AI-powered medtech with a platform that proves helpful in detecting diagnoses and opening paths to new treatments.

February 10, 2024 | markets.businessinsider.com

BullFrog AI Shares Insights in New FD Disclosure Statement

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.

February 9, 2024 | finance.yahoo.com

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

February 7, 2024 | msn.com

BullFrog AI Holdings Clinches $5.7M Capital Raise Deal

February 7, 2024 | msn.com

BullFrog AI Announces Pricing and Closing of Offering

February 5, 2024 | finance.yahoo.com

WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering

February 1, 2024 | finance.yahoo.com

WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering

February 12, 2024 | The Freeport Society (Ad)

Obama’s 2024 Confession

Barack Obama’s confession about the 2024 election just leaked online… In short, he’s worried Biden “could very well lose.” But before you think that means Trump will win… You should see the evidence I’ve found about an election shock that could come as soon as August 19th.

January 18, 2024 | msn.com

Premarket Action Heats Up For This Micro Cap

January 17, 2024 | msn.com

BullFrog AI Stock Is Soaring Wednesday: What's Going On?

January 17, 2024 | investorplace.com

Why Is Bullfrog AI (BFRG) Stock Up 30% Today?

January 17, 2024 | uk.finance.yahoo.com

Bullfrog AI Holdings, Inc. (BFRG)

January 17, 2024 | finance.yahoo.com

BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

January 16, 2024 | msn.com

BullFrog AI says Australian patent issued for prodrugs of mebendazole

January 16, 2024 | finance.yahoo.com

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

January 11, 2024 | finance.yahoo.com

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

January 10, 2024 | benzinga.com

Bullfrog AI Hldgs Stock (NASDAQ:BFRG) Dividends: History, Yield and Dates

January 5, 2024 | morningstar.com

Bullfrog AI Holdings Inc BFRG

December 31, 2023 | nasdaq.com

Bullfrog AI Holdings, Inc. Common Stock (BFRG)

December 29, 2023 | finance.yahoo.com

BullFrog AI Issues Letter to Shareholders

October 18, 2023 | finance.yahoo.com

BullFrog AI to Present at Benzinga All Access Event on October 20

October 5, 2023 | stockhouse.com

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP(TM) Platform

October 5, 2023 | finance.yahoo.com

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

September 26, 2023 | benzinga.com

Why Bullfrog AI Holdings Stock Is Jumping Today

September 26, 2023 | finance.yahoo.com

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

September 25, 2023 | finance.yahoo.com

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

See More Headlines

Receive BFRG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bullfrog AI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/14/2023
Today: 2/11/2024
Next Earnings (Estimated): 2/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:BFRG
CUSIP: N/A
CIK: 1829247
Web: www.bullfrogai.com
Phone: 240-658-6710
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,800,000.00
Net Margins: N/A
Pretax Margin: -6,338.67%
Return on Equity: -185.78%
Return on Assets: -114.76%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.44
Quick Ratio: 9.43

Sales & Book Value

Annual Sales: $75,000.00
Price / Sales: 407.15
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 6,095,000
Free Float: N/A
Market Cap: $30.54 million
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Vininder Singh (Age 54)
Founder, Chairman & CEO
Comp: $707.67k
Mr. Dane R. Saglio (Age 66)
Chief Financial Officer
Comp: $360k
Mr. J. T. Koffenberger
Chief Information Officer
Dr. Cetin Savkli
Chief AI Advisor & Member of Advisory Board
Mr. William Hirschman
Chief Commercial Officer
Dr. David P. Recker FACP (Age 66)
FACR, M.D., Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BFRG Stock Analysis - Frequently Asked Questions

How have BFRG shares performed in 2024?: Bullfrog AI's stock was trading at $3.26 at the beginning of 2024. Since then, BFRG shares have increased by 53.7% and is now trading at $5.01.
View the best growth stocks for 2024 here.
When is Bullfrog AI's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our BFRG earnings forecast.
How were Bullfrog AI's earnings last quarter?: Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) announced its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.21) earnings per share (EPS) for the quarter. The company earned $0.07 million during the quarter.

When did Bullfrog AI IPO?: (BFRG) raised $8 million in an IPO on Tuesday, February 14th 2023. The company issued 1,300,000 shares at a price of $6.50 per share. WallachBeth Capital and Kingswood Capital Markets acted as the underwriters for the IPO.
How do I buy shares of Bullfrog AI?: Shares of BFRG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BFRG) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial